Published in Gene Therapy Weekly, July 27th, 2000
"Genetic immunization is a promising new technology for developing vaccines against tuberculosis that are more effective," wrote G. Delogu and colleagues, from the U.S. Food and Drug Administration. "In the present study, we evaluated the effects of intracellular turnover of antigens expressed by DNA vaccines on the immune response induced by these vaccines in a mouse model of pulmonary tuberculosis."
Delogu et al. published their study in Infection and Immunity ("DNA vaccination against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.